Inhibiting stemness and invasive properties of glioblastoma tumorsphere by combined treatment with temozolomide and a newly designed biguanide (HL156A).

Oncotarget · 2016 · PMC5323181 · PMID 27582539

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

fell short of significanceno p-value reported

This latter effect was additive, although there was a trend towards synergy that fell short of significance.

also in 361 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.